Status:
UNKNOWN
Early Extracorporeal Shockwave Therapy for Erectile Dysfunction in Radically Prostatectomised Men.
Lead Sponsor:
Odense University Hospital
Conditions:
Erectile Dysfunction
Extracorporeal Shockwave Therapy
Eligibility:
MALE
20-80 years
Phase:
NA
Brief Summary
The purpose of this project is to assess the relationship between low intensity shock wave treatment (LI-SWT) and erectile function (ED) in patients who have undergone radical prostatectomy (RP).
Eligibility Criteria
Inclusion
- Radically prostatectomised men
- Non nerve-sparing or nerve-sparing RP.
- Age 20-80 years
- Have been in a relationship for more than 3 months.
- Sexually active
- Patient can give informed consent.
Exclusion
- Men with ED of neuropathological or psychogenic origin
- Rectal extirpation, radiation therapy to the pelvic area and recovery from any other cancer within the past 5 years are excluded.
- Patients with heart disease prohibiting sexual activity or taking medication with antiandrogens, anticoagulant (apart from aspirin) or systemic use of glucocorticoids within 5 weeks.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04059341
Start Date
September 1 2019
End Date
July 1 2020
Last Update
August 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital
Odense, Denmark, 5000